# CABA (Cabaletta Bio, Inc.) - SEC EDGAR Financial Statements

> Cabaletta Bio, Inc. reported $336.5M in total assets and a net loss of $189.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CABA
- Markdown: https://convexityos.com/fundamentals/CABA.md
- SEC CIK: 0001759138
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:40 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001759138&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$193.6M | Operating profit |
| Net Income | FY 2025 | -$189.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$162.5M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $299.4M | Total debt: $23.17M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $142.7M | $97.20M | $55.42M | $39.30M | $32.49M | $21.38M | $11.67M | $4.47M |
| Total Operating Expenses | $172.2M | $125.1M | $74.66M | $54.14M | $46.31M | $33.83M | $18.68M | $6.19M |
| **Operating Income** | -$172.2M | -$125.1M | -$74.66M | -$54.14M | -$46.31M | -$33.83M | -$18.68M | -$6.19M |
| **EBITDA** | -$170.6M | -$123.4M | -$73.23M | -$52.96M | -$45.58M | -$33.48M | -$18.58M | -$6.19M |
| Interest Income | $6.03M | $10.03M | $6.99M | $1.16M | $24K | $494K | $1.74M | $235K |
| Interest Expense | $2.00M | $748K | $0 | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$167.9M | -$115.9M | -$67.67M | -$52.98M | -$46.29M | -$33.34M | -$16.94M | -$12.20M |
| Basic EPS | -$2.10 | -$2.34 | -$1.65 | -$1.81 | -$1.80 | -$1.44 | -$4.07 | -$6.87 |
| **Diluted EPS** | -$2.10 | -$2.34 | -$1.65 | -$1.81 | -$1.80 | -$1.44 | -$4.07 | -$6.87 |
| Basic Shares Outstanding | -- | -- | 1.2M | 5.9M | -- | -- | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $47.14M | $44.43M | $37.35M | $36.19M | $39.82M | $37.64M | $29.02M | $25.53M |
| Total Operating Expenses | $54.71M | $52.02M | $44.30M | $42.61M | $46.59M | $45.91M | $37.14M | $33.78M |
| **Operating Income** | -$54.71M | -$52.02M | -$44.30M | -$42.61M | -$46.59M | -$45.91M | -$37.14M | -$33.78M |
| **EBITDA** | -$54.36M | -$51.65M | -$43.96M | -$42.26M | -$46.24M | -$45.44M | -$36.65M | -$33.32M |
| Interest Income | $2.14M | $1.60M | $1.08M | $1.33M | $1.81M | $1.41M | $1.49M | $1.95M |
| Interest Expense | $511K | $517K | $636K | $555K | $584K | $571K | $294K | $748K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$53.05M | -$51.02M | -$43.52M | -$41.92M | -$44.87M | -$45.13M | -$35.94M | -$32.59M |
| Basic EPS | -$0.28 | -$0.34 | -$0.39 | -- | -$0.44 | -$0.73 | -$0.71 | -- |
| **Diluted EPS** | -$0.28 | -$0.34 | -$0.39 | -- | -$0.44 | -$0.73 | -$0.71 | -- |
| Basic Shares Outstanding | 186.8M | 151.2M | 112.0M | -- | 102.3M | 61.9M | 50.7M | -- |
| Diluted Shares Outstanding | 186.8M | 151.2M | 112.0M | -- | 102.3M | 61.9M | 50.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $82.98M | $164.0M | $193.2M | $81.61M | $122.2M | $101.4M | $136.2M | $33.02M |
| Short-Term Investments | $50.62M | $0 | $48.01M | $24.94M | $0 | $7.23M | -- | -- |
| **Cash & Short-Term Investments** | $133.6M | $164.0M | $241.2M | $106.5M | $122.2M | $108.7M | $136.2M | $33.02M |
| **Total Current Assets** | $138.9M | $166.7M | $244.5M | $108.8M | $124.5M | $113.5M | $140.6M | $33.99M |
| Property, Plant & Equipment, Net | $1.92M | $2.74M | $2.54M | $2.58M | $1.44M | $890K | $815K | -- |
| Other Non-Current Assets | $5.16M | $2.29M | $1.71M | $565K | $357K | $299K | $101K | -- |
| **Total Non-Current Assets** | $26.21M | $18.37M | $9.16M | $8.13M | $1.79M | $1.19M | $916K | $180K |
| **Total Assets** | $165.1M | $185.0M | $253.7M | $117.0M | $126.3M | $114.7M | $141.5M | $34.17M |
| Accounts Payable | $6.64M | $4.92M | $4.55M | $2.46M | $2.33M | $1.24M | $920K | $603K |
| Other Current Liabilities | $80K | $40K | $40K | $39K | $54K | $38K | $177K | $2.0K |
| **Total Current Liabilities** | $50.15M | $27.09M | $15.99M | $9.49M | $8.38M | $5.18M | $3.15M | $943K |
| **Total Non-Current Liabilities** | $2.88M | $5.62M | $1.46M | $2.96M | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $53.03M | $32.71M | $17.45M | $12.45M | $8.38M | $5.18M | $3.15M | $943K |
| **Total Debt (incl. Leases)** | $27.10M | $15.60M | $5.02M | $1.53M | -- | -- | -- | -- |
| Common Stock | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$517.0M | -$349.1M | -$233.2M | -$165.6M | -$112.6M | -$66.30M | -$32.96M | -$12.45M |
| Accumulated Other Comp. Income | $25K | $0 | $39K | -$47K | $0 | $6.0K | -- | -- |
| **Total Stockholders' Equity** | $112.1M | $152.3M | $236.2M | $104.5M | $118.0M | $109.5M | $138.3M | -$10.69M |
| Total Equity | $112.1M | $152.3M | $236.2M | $104.5M | $118.0M | $109.5M | $138.3M | -$10.69M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $299.4M | $225.1M | $116.6M | $82.98M | $60.21M | $145.6M | $131.8M | $164.0M |
| Short-Term Investments | $0 | $0 | $0 | $50.62M | $99.72M | $49.07M | -- | $0 |
| **Cash & Short-Term Investments** | $299.4M | $225.1M | $116.6M | $133.6M | $159.9M | $194.7M | $131.8M | $164.0M |
| **Total Current Assets** | $309.8M | $231.0M | $122.3M | $138.9M | $164.6M | $198.4M | $134.6M | $166.7M |
| Property, Plant & Equipment, Net | $1.01M | $1.48M | $1.58M | $1.92M | $2.06M | $2.37M | $2.64M | $2.74M |
| Other Non-Current Assets | $8.57M | $6.21M | $5.27M | $5.16M | $3.61M | $2.50M | $2.37M | $2.29M |
| **Total Non-Current Assets** | $26.64M | $25.70M | $25.83M | $26.21M | $25.20M | $26.09M | $30.55M | $18.37M |
| **Total Assets** | $336.5M | $256.7M | $148.1M | $165.1M | $189.8M | $224.5M | $165.1M | $185.0M |
| Accounts Payable | $9.04M | $5.81M | $6.38M | $6.64M | $8.27M | $7.19M | $6.49M | $4.92M |
| Other Current Liabilities | $70K | $60K | $90K | $80K | $30K | $16K | $50K | $40K |
| **Total Current Liabilities** | $47.33M | $39.91M | $41.51M | $50.15M | $45.73M | $41.54M | $33.99M | $27.09M |
| **Total Non-Current Liabilities** | $5.24M | $6.22M | $3.33M | $2.88M | $4.56M | $4.48M | $9.60M | $5.62M |
| **Total Liabilities** | $52.57M | $46.13M | $44.84M | $53.03M | $50.29M | $46.02M | $43.59M | $32.71M |
| **Total Debt (incl. Leases)** | $23.17M | $25.71M | $26.45M | $27.10M | $25.78M | $24.89M | $28.79M | $15.60M |
| Common Stock | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$664.5M | -$611.5M | -$560.5M | -$517.0M | -$475.0M | -$430.2M | -$385.0M | -$349.1M |
| Accumulated Other Comp. Income | $0 | $0 | $0 | $25K | $23K | $1.0K | -- | $0 |
| **Total Stockholders' Equity** | $283.9M | $210.6M | $103.3M | $112.1M | $139.5M | $178.5M | $121.6M | $152.3M |
| Total Equity | $283.9M | $210.6M | $103.3M | $112.1M | $139.5M | $178.5M | $121.6M | $152.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$167.9M | -$115.9M | -$67.67M | -$52.98M | -$46.29M | -$33.34M | -$16.94M | -$12.20M |
| Depreciation & Amortization | $1.65M | $1.71M | $1.43M | $1.18M | $733K | $354K | $104K | $0 |
| Stock-Based Compensation | $20.94M | $19.46M | $11.34M | $6.90M | $5.80M | $4.39M | $2.30M | $606K |
| Change in Payables | $1.55M | $1.01M | $1.68M | -$28K | $975K | $555K | $246K | $234K |
| **Operating Cash Flow** | -$131.1M | -$88.22M | -$53.55M | -$46.38M | -$34.11M | -$26.77M | -$16.05M | -$4.66M |
| Capital Expenditure | -$1.23M | -$2.21M | -$687K | -$2.45M | -$1.17M | -$635K | -$693K | -- |
| **Free Cash Flow** | -$132.3M | -$90.43M | -$54.24M | -$48.83M | -$35.27M | -$27.41M | -$16.74M | -- |
| Purchases of Investments | -$99.04M | $0 | -$84.26M | -$49.76M | $0 | -$11.10M | -- | -- |
| **Investing Cash Flow** | -$50.27M | $47.29M | -$22.45M | -$27.22M | $6.00M | -$7.98M | -$693K | -- |
| Common Stock Issued | $93.56M | $0 | $185.2M | $32.85M | $48.25M | -$192K | $71.21M | -- |
| **Financing Cash Flow** | $100.3M | $11.68M | $187.6M | $32.98M | $48.90M | -$24K | $119.9M | $37.68M |
| **Net Change in Cash** | -$80.98M | -$29.28M | $111.6M | -$40.62M | $20.79M | -$34.77M | $103.2M | $33.02M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$53.05M | -$51.02M | -$43.52M | -$41.92M | -$44.87M | -$45.13M | -$35.94M | -$32.59M |
| Depreciation & Amortization | $347K | $371K | $337K | $348K | $345K | $468K | $485K | $468K |
| Stock-Based Compensation | $5.26M | $5.50M | $5.26M | $4.26M | $5.82M | $5.71M | $5.16M | $5.41M |
| Change in Payables | $3.42M | -$908K | -$269K | -$1.71M | $1.07M | $595K | $1.59M | $2.70M |
| **Operating Cash Flow** | -$42.74M | -$41.51M | -$42.56M | -$35.34M | -$34.51M | -$30.43M | -$30.80M | -$23.12M |
| Capital Expenditure | -$142K | $0 | $0 | -$205K | -$78K | -$161K | -$785K | -$376K |
| **Free Cash Flow** | -$42.89M | -$41.51M | -$42.56M | -$35.55M | -$34.59M | -$30.59M | -$31.59M | -$23.50M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | -$142K | $0 | $50.96M | $49.80M | -$50.08M | -$49.20M | -$785K | $12.12M |
| Common Stock Issued | $115.0M | $6.25M | $6.94M | $93.56M | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $117.2M | $150.0M | $25.27M | $8.33M | -$806K | $93.37M | -$552K | $4.37M |
| **Net Change in Cash** | $74.28M | $108.5M | $33.65M | $22.78M | -$85.41M | $13.78M | -$32.13M | -$6.65M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -149.8% | -76.1% | -28.7% | -50.7% | -39.2% | -30.4% | -12.2% | -- |
| Return on Assets (ROA) | -101.7% | -62.6% | -26.7% | -45.3% | -36.6% | -29.1% | -12.0% | -35.7% |
| Current Ratio | 2.77x | 6.15x | 15.29x | 11.47x | 14.86x | 21.92x | 44.66x | 36.05x |
| Quick Ratio | 2.66x | 6.05x | 15.08x | 11.23x | 14.58x | 20.98x | 43.28x | 35.01x |
| Debt to Equity | 0.24x | 0.10x | 0.02x | 0.01x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -66.7% | -86.1% | -169.8% | -149.8% | -113.7% | -80.8% | -104.3% | -76.1% |
| Return on Assets (ROA) | -56.3% | -70.6% | -118.4% | -101.7% | -83.5% | -64.3% | -76.8% | -62.6% |
| Current Ratio | 6.55x | 5.79x | 2.95x | 2.77x | 3.60x | 4.78x | 3.96x | 6.15x |
| Quick Ratio | 6.33x | 5.64x | 2.81x | 2.66x | 3.50x | 4.69x | 3.88x | 6.05x |
| Debt to Equity | 0.08x | 0.12x | 0.26x | 0.24x | 0.18x | 0.14x | 0.24x | 0.10x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
